|Articles|June 29, 2021

Guiding Antibiotic Stewardship Programs in an Outpatient Setting

Author(s)Killian Meara

Post-intervention saw 55% of patients receive overall guideline-concordant antibiotics.

A significant leading threat to public health safety around the world has been the growing of antibiotic resistance. Research has found that around half of current antibiotic prescriptions were unnecessary or inappropriate in the outpatient setting.

Recently, investigators from the University of Texas’ Health Science Center McGovern Medical School conducted a multimodal assessment to aid antibiotics stewardship program activities and interventions.

The data was presented at the 2021 Association for Professionals in Infection Control and Epidemiology conference virtual sessions.

For the assessment, the team of investigators developed a patient and provider survey which assessed knowledge, attitude, and behavior towards antibiotics.

To assess antibiotic use pre- and post-intervention for a 6-month period, investigators provided a verbal education and a flow chart to providers in 2 clinics describing the 2010-IDSA/ESCMID guidelines for treatment of uncomplicated cystitis.

Findings from the assessment showed that of the 85 participants who took the patient survey, 38% recognized the relationship between over usage and the emergence of antibiotic-resistant organisms.

Additionally, 17% felt that they were wasting their time if they go to a doctor with an infection and they were not prescribed an antibiotic and 86% said they wanted to learn more about antibiotics.

In the provider surveys, participants chose guideline-appropriate treatment for acute uncomplicated cystitis 56% of the time, and 44% of the time for uncomplicated pyelonephritis.

The pre-intervention saw 24 patients (65%) receive an antibiotic with a guideline concordant dose, duration, and frequency. In the post-intervention, 12 patients (32%) received a longer duration than recommended.

“There is an unmet need to address patient and provider knowledge deficits and behaviors towards antibiotics,” the authors wrote. “Future projects will need to include a more active approach to antibiotic stewardship in order to engage both patients and providers.”


Related to this article

IDSA/ESCMID Statement on Staphylococcus aureus: Follow-Up Blood Cultures
Staphylococcus aureus Bacteremia (SAB) causes significant morbidity and globally is the leading cause of death from bloodstream infection. This month, the IDSA and ESCMID released 7 consensus statements to assist in managing individuals with SAB. This review will focus on the adult patient population and additional information on pediatric population statements can be assessed in the guideline. Here is a closer look at Consensus Statement 2: Follow-up Blood Cultures.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.